Anqi Wei is a China Associate in the Litigation practice of Paul Hastings and is based in the firm's Shanghai office.
Ms. Wei advises clients regarding various compliance related matters, including internal compliance investigations, compliance-related due diligence, designing and enhancing compliance programs, and anti-corruption training. Ms. Wei also has experience supporting general corporate matters.
Ms. Wei has been with the Paul Hastings litigation team since June 2017.
Ms. Wei passed the PRC bar in 2018, but does not hold a current practicing certificate. Ms. Wei is fluent in English and Mandarin.
Tsinghua University, LL.B., 2018
Conducted a series of significant internal investigations on behalf of several global biopharmaceutical companies for its mainland China operations involving improper payments, books and records violations, embezzlement and other compliance related issues.
Conducted internal investigations on behalf of an international medical device company for its subsidiary's business operations in mainland China and advised the client in the subsequent DOJ self-reporting proceedings under the FCPA.
Conducted several internal investigations of potential contract fraud and improper payments by the China sales team of leading global software and cloud service providers.
Advised multiple international investors in several high-stake real estate acquisitions with respect to compliance due diligence.
Advised one of the largest integrated shipping companies in China on CFIUS compliance matters with respect to its substantial acquisition.
Drafted compliance policies and procedures for a leading technology company and a Singapore-based life science private equity firm.
Advised a global leading architecture design firm in its China licensing efforts and related corporate transactions and filings.